On 2014 Mar 09, Mao Mao commented:
This is a cost-effective, single tube assay for screening all three lung cancer targetable gene fusions in NSCLC patients. We also report a novel RET fusion (CUX1-RET) in the paper.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.